FDA Inspection 1194198 — Taro Pharmaceutical Industries Ltd.
The FDA completed an inspection of Taro Pharmaceutical Industries Ltd. on December 8, 2022 in Haifa Bay. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 8, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Haifa Bay (Israel)